HIV i-Base and Treatment Action Group (TAG) called on global and national leaders, research sponsors, and regulatory authorities to work together to make the best HIV, HCV, and TB drugs, diagnostics, and vaccines accessible as fast as possible, according to a report released today at the 7th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Kuala Lumpur, Malaysia.
The week of November 12th was exciting with the 43rd Union World Conference, the WGND Annual Meeting (will be posting presentations soon), and the Stop TB Coordinating Board Meeting. Included are some news highlights and a listing of webcasts of interesting and presentations relevant for TB drug development and research.
he 21st Stop TB Partnership Coordinating Board retreat and meeting officially started in Bangkok, Thailand, on Sunday, January 29th with the official opening ceremony held yesterday January 30th. Included are some exciting news from the meeting courtesy of Mark Harrington, Executive Director of the Treatment Action Group (TAG).
Treatment Action Group (TAG) recently released their TAG 2010 Pipeline Report, an annual report that explores the progress and overall state of drug development in the fields of HIV, Tuberculosis, and Viral Hepatitis. The report covers the development of drugs, diagnostics, vaccines, immune-based therapies, and preventative technologies in development in each field.
Register Now for Open Forum 4: Key Issues in TB Drug Development.
August 18-19, 2010 | Addis Ababa, Ethiopia
The conference will address key issues in TB drug development, with a special focus on regulatory affairs. This upcoming event will highlight TB drug development challenges in light of new treatment advances and feature keynote addresses from thought leaders in the field of tuberculosis.